Synfacts 2018; 14(01): 0001
DOI: 10.1055/s-0036-1592050
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Pilot-Scale Synthesis of TV-45070

Philip Kocienski
Sclafani JA. * Teva Branded Pharmaceutical Products R&D, Malvern, USA
The First Asymmetric Pilot-Scale Synthesis of TV-45070.

Org. Process Res. Dev. 2017;
21: 1616-1624
Further Information

Publication History

Publication Date:
15 December 2017 (online)



TV-45070 is an antagonist of the Nav1.7 sodium ion channel protein that is of interest for the treatment of chronic pain associated with shingles. The key step in the synthesis depicted is the asymmetric aldol reaction of the enolate derived from E with a mixture of solid paraform­aldehyde and aqueous formaldehyde using only 1.1 mol% of thiourea catalyst F to give adduct G in 96% yield and 70.5% ee. This solid product was heated in MeOH at 50 °C and cooled to 20 °C whereupon the near racemic product G (5% ee) precipitated. Addition of water to the supernatent afforded (S)-H in 99% ee and 58% yield.



Attempts to synthesize chloro or mesylate intermediates from diol H using conventional reagents were unsuccessful due to the congested neopentyl center. Diethyl chlorophosphate, dichlorophenyl phosphine, and diethylchlorophosphite did not provide sufficient conversion or a good impurity profile. However, chlorodiphenylphosphine completely consumed H when heated to 37 °C and provided the spirocycle in 81% yield. For a preceding asymmetric synthesis of TV-45070, see: S. Sun et al. US 9,487,535, 2016. For a synthesis of catalyst F, see: Y. Wang et al. Org. Process Res. Dev. 2017, 21, 408.